{"database": "openregs", "table": "documents", "is_view": false, "human_description_en": "where docket_id = \"FDA-2010-P-0628\" sorted by posted_date descending", "rows": [["FDA-2010-P-0628-0010", "FDA", "FDA-2010-P-0628", "FDA/CDER Response to Heyl Chemisch-Pharmazeutische Fabrik GmbH & Co. KG - Letter", "Other", "Letter(s)", "2011-08-24T04:00:00Z", 2011, 8, "2011-08-24T04:00:00Z", null, "2012-05-09T22:55:06Z", null, 0, 0, "0900006480eeb82b"], ["FDA-2010-P-0628-0009", "FDA", "FDA-2010-P-0628", "Determination That PENTETATE CALCIUM TRISODIUM (Trisodium Calcium Diethylenetriaminepentaacetate) Solution for Intravenous or Inhalation Administration, Equivalent to 1 Gram Base/5 Milliliters (Equivalent to 200 Milligrams Base/Milliliter), Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness", "Notice", "General Notice", "2011-08-19T04:00:00Z", 2011, 8, null, null, "2012-05-09T22:45:19Z", "2011-21227", 0, 0, "0900006480ee56e2"], ["FDA-2010-P-0628-0004", "FDA", "FDA-2010-P-0628", "Attachment I - \"Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations\" - Heyltex Corporation [Heyl Chemisch-pharmazeutische Fabrik GnbH & Co. KG - Citizen Petition]", "Supporting & Related Material", "CP-Citizen Petition (Supporting & Related Materials)", "2010-12-27T05:00:00Z", 2010, 12, null, null, "2010-12-27T19:14:05Z", null, 0, 0, "0900006480bb2c17"], ["FDA-2010-P-0628-0006", "FDA", "FDA-2010-P-0628", "Attachment V - Breustedt, B. et al, \"Development of biokinetic models for the description of the effect of DTPA with regard to the diagnostic and therapy of incorporation of plutonium and other transuranium elements\" - Heyltex Corporation [Heyl Chemisch-pharmazeutische Fabrik GnbH & Co. KG - Citizen Petition]", "Supporting & Related Material", "CP-Citizen Petition (Supporting & Related Materials)", "2010-12-27T05:00:00Z", 2010, 12, null, null, "2010-12-27T19:18:35Z", null, 0, 0, "0900006480bb30db"], ["FDA-2010-P-0628-0007", "FDA", "FDA-2010-P-0628", "Attachment VII - \"Mayak Worker Study Project 2.4 Volume III Internal Dosimetry Dose Reconstruction Methods Used in Preparation of Doses-2005 Database\" - Heyltex Corporation [Heyl Chemisch-pharmazeutische Fabrik GnbH & Co. KG - Citizen Petition]", "Supporting & Related Material", "CP-Citizen Petition (Supporting & Related Materials)", "2010-12-27T05:00:00Z", 2010, 12, null, null, "2010-12-27T19:19:56Z", null, 0, 0, "0900006480bb30de"], ["FDA-2010-P-0628-0005", "FDA", "FDA-2010-P-0628", "Attachment II - \"Federal Register/ Vol. 68, No. 178/ Monday, September 15, 2003/Notice\" - Heyltex Corporation [Heyl Chemisch-pharmazeutische Fabrik GnbH & Co. KG - Citizen Petition]", "Supporting & Related Material", "CP-Citizen Petition (Supporting & Related Materials)", "2010-12-27T05:00:00Z", 2010, 12, null, null, "2010-12-27T19:16:46Z", null, 0, 0, "0900006480bb2c18"], ["FDA-2010-P-0628-0008", "FDA", "FDA-2010-P-0628", "Attachment XI - \"IPCS Evaluation of Antidotes for Poisoning by Metals and Metalloids\" Heyltex Corporation [Heyl Chemisch-pharmazeutische Fabrik GnbH & Co. KG - Citizen Petition]", "Supporting & Related Material", "CP-Citizen Petition (Supporting & Related Materials)", "2010-12-27T05:00:00Z", 2010, 12, null, null, "2010-12-27T19:36:22Z", null, 0, 0, "0900006480bb30e2"], ["FDA-2010-P-0628-0003", "FDA", "FDA-2010-P-0628", "Acknowledgement Letter to Heyltex Corporation, Heyl Chemisch-Pharmazeutische Fabrik GnbH & Co. KG - Correction", "Other", "CR-Correction", "2010-12-22T05:00:00Z", 2010, 12, "2010-12-22T05:00:00Z", null, "2013-07-27T23:40:14Z", null, 0, 0, "0900006480bbd27f"], ["FDA-2010-P-0628-0001", "FDA", "FDA-2010-P-0628", "Heyltex Corporation, Heyl Chemisch-Pharmazeutische Fabrik GnbH & Co. KG - Citizen Petition", "Other", "CP-Citizen Petition", "2010-12-20T05:00:00Z", 2010, 12, "2010-12-20T05:00:00Z", null, "2013-07-27T23:39:14Z", null, 0, 0, "0900006480bb2bb2"], ["FDA-2010-P-0628-0002", "FDA", "FDA-2010-P-0628", "Acknowledgement Letter to Heyltex Corporation, Heyl Chemisch-Pharmazeutische Fabrik GnbH & Co. KG", "Other", "Acknowledgement Letter/Receipt", "2010-12-20T05:00:00Z", 2010, 12, "2010-12-20T05:00:00Z", null, "2013-08-11T04:43:15Z", null, 0, 0, "0900006480bb32df"]], "truncated": false, "filtered_table_rows_count": 10, "expanded_columns": [], "expandable_columns": [[{"column": "docket_id", "other_table": "dockets", "other_column": "id"}, "title"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "units": {}, "query": {"sql": "select id, agency_id, docket_id, title, document_type, subtype, posted_date, posted_year, posted_month, comment_start_date, comment_end_date, last_modified, fr_doc_num, open_for_comment, withdrawn, object_id from documents where \"docket_id\" = :p0 order by posted_date desc limit 101", "params": {"p0": "FDA-2010-P-0628"}}, "facet_results": {"agency_id": {"name": "agency_id", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?docket_id=FDA-2010-P-0628", "results": [{"value": "FDA", "label": "FDA", "count": 10, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2010-P-0628&agency_id=FDA", "selected": false}], "truncated": false}, "document_type": {"name": "document_type", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?docket_id=FDA-2010-P-0628", "results": [{"value": "Supporting & Related Material", "label": "Supporting & Related Material", "count": 5, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2010-P-0628&document_type=Supporting+%26+Related+Material", "selected": false}, {"value": "Other", "label": "Other", "count": 4, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2010-P-0628&document_type=Other", "selected": false}, {"value": "Notice", "label": "Notice", "count": 1, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2010-P-0628&document_type=Notice", "selected": false}], "truncated": false}, "posted_year": {"name": "posted_year", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?docket_id=FDA-2010-P-0628", "results": [{"value": 2010, "label": 2010, "count": 8, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2010-P-0628&posted_year=2010", "selected": false}, {"value": 2011, "label": 2011, "count": 2, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2010-P-0628&posted_year=2011", "selected": false}], "truncated": false}}, "suggested_facets": [{"name": "subtype", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2010-P-0628&_facet=subtype"}, {"name": "posted_date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2010-P-0628&_facet=posted_date"}, {"name": "posted_month", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2010-P-0628&_facet=posted_month"}, {"name": "comment_start_date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2010-P-0628&_facet=comment_start_date"}, {"name": "posted_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2010-P-0628&_facet_date=posted_date"}, {"name": "comment_start_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2010-P-0628&_facet_date=comment_start_date"}, {"name": "last_modified", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2010-P-0628&_facet_date=last_modified"}], "next": null, "next_url": null, "private": false, "allow_execute_sql": true, "query_ms": 9.537124074995518, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}